Quote:

---

Hey ohm, speaking of a phase 3 for immune activation, do you have any idea how much bigger and longer that trial might be?

---

I would expect the trial to last one year. That should be long enough to prove it out. Size is going to be determined by what efficacy is shown. 300 patients should be sufficient but we'll have to wait for the results from the phase 2 to get a better idea..